Secondary Short Bowel Syndrome

Watchlist

(log in to enable)

Retrieved

2021-01-23

Source

Orphanet

Trials

—

Genes

—

Drugs

Apraglutide, Heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148, Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment

Apraglutide, Heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148, Human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment, Insulin human, Oxalobacter formigenes strain HC-1, Teduglutide ( GATTEX, REVESTIVE )

Interested in hearing about new therapies?

Secondary short bowel syndrome is an intestinal failure caused by any condition that results in a functional small intestine of less than 200 cm in length and is characterized by diarrhea, nutrient malabsoption, bowel dilation and dysmobility.